Clinical Trial Update: NTX-001 to Repair Peripheral Nerve Transection(s)

View source ↗

Summary

Update on a clinical trial evaluating NTX-001 for repairing acute or planned peripheral nerve transections in the upper extremity and facial nerves.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Nerve Injury

Drugs mentioned

• NTX-001

Snippet

Sponsor: Neuraptive Therapeutics Inc. | Conditions: Peripheral Nerve Transections, Acute or Planned in Upper Extremity and Facial Nerves | Status: AVAILABLE